BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37071004)

  • 21. Child type 1 diabetes associated with mother vaginal bacteriome and mycobiome.
    Ruotsalainen AL; Tejesvi MV; Vänni P; Suokas M; Tossavainen P; Pirttilä AM; Talvensaari-Mattila A; Nissi R
    Med Microbiol Immunol; 2022 Aug; 211(4):185-194. PubMed ID: 35701558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EnsembleSeq: a workflow towards real-time, rapid, and simultaneous multi-kingdom-amplicon sequencing for holistic and resource-effective microbiome research at scale.
    Nagpal S; Mande SS; Hooda H; Dutta U; Taneja B
    Microbiol Spectr; 2024 Jun; 12(6):e0415023. PubMed ID: 38687072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucosal immune cell populations and the bacteriome of adenoids and tonsils from people living with HIV on suppressive antiretroviral therapy.
    Briceño O; Gónzalez-Navarro M; Montufar N; Chávez-Torres M; Abato I; Espinosa-Sosa A; Ablanedo-Terrazas Y; Luna-Villalobos Y; Ávila-Ríos S; Reyes-Terán G; Pinto-Cardoso S
    Front Microbiol; 2022; 13():958739. PubMed ID: 36033845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral bacteriome and mycobiome of patients with idiopathic membranous nephropathy with different tongue coatings treated with a Chinese herbal formula.
    Wang XH; Yang YN; Li YH; Cheng JL; Yan L; Liang Y; Zeng Q; Zhan T; Wang DW; Yu RH; Wu CM
    J Ethnopharmacol; 2024 Sep; 331():118233. PubMed ID: 38685365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration in Oral Microbiome Among Men Who Have Sex With Men With Acute and Chronic HIV Infection on Antiretroviral Therapy.
    Li S; Zhu J; Su B; Wei H; Chen F; Liu H; Wei J; Yang X; Zhang Q; Xia W; Wu H; He Q; Zhang T
    Front Cell Infect Microbiol; 2021; 11():695515. PubMed ID: 34336719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Gut Mycobiome and Fungal Community Interaction: The Unknown Musketeer in the Chemotherapy Response Status in Bladder Cancer.
    Bukavina L; Prunty M; Isali I; Calaway A; Ginwala R; Sindhani M; Ghannoum M; Mishra K; Kutikov A; Uzzo RG; Ponsky LE; Abbosh PH
    Eur Urol Open Sci; 2022 Sep; 43():5-13. PubMed ID: 36353067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The intestinal microbiota and metabolites in patients with anorexia nervosa.
    Prochazkova P; Roubalova R; Dvorak J; Kreisinger J; Hill M; Tlaskalova-Hogenova H; Tomasova P; Pelantova H; Cermakova M; Kuzma M; Bulant J; Bilej M; Smitka K; Lambertova A; Holanova P; Papezova H
    Gut Microbes; 2021; 13(1):1-25. PubMed ID: 33779487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional biomes beyond the bacteriome in the oral ecosystem.
    Girija ASS; Ganesh PS
    Jpn Dent Sci Rev; 2022 Nov; 58():217-226. PubMed ID: 35814739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The respiratory microbiome of HIV-infected individuals.
    Lawani MB; Morris A
    Expert Rev Anti Infect Ther; 2016 Aug; 14(8):719-29. PubMed ID: 27348261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The primate gut mycobiome-bacteriome interface is impacted by environmental and subsistence factors.
    Sharma AK; Davison S; Pafco B; Clayton JB; Rothman JM; McLennan MR; Cibot M; Fuh T; Vodicka R; Robinson CJ; Petrzelkova K; Gomez A
    NPJ Biofilms Microbiomes; 2022 Mar; 8(1):12. PubMed ID: 35301322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critically Appraising the Significance of the Oral Mycobiome.
    Diaz PI; Dongari-Bagtzoglou A
    J Dent Res; 2021 Feb; 100(2):133-140. PubMed ID: 32924741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulating the skin mycobiome-bacteriome and treating seborrheic dermatitis with a probiotic-enriched oily suspension.
    Truglio M; Sivori F; Cavallo I; Abril E; Licursi V; Fabrizio G; Cardinali G; Pignatti M; Toma L; Valensise F; Cristaudo A; Pimpinelli F; Di Domenico EG
    Sci Rep; 2024 Feb; 14(1):2722. PubMed ID: 38302693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Analysis of Salivary Mycobiome Diversity in Human Immunodeficiency Virus-Infected Patients.
    Chang S; Guo H; Li J; Ji Y; Jiang H; Ruan L; Du M
    Front Cell Infect Microbiol; 2021; 11():781246. PubMed ID: 34926323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Human mycobiome and diseases].
    Shen X; Yao YF; Li JY; Li Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Jun; 37(3):314-319. PubMed ID: 31218869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis.
    Tseng CW; Dudley RA; Chen R; Walensky RP
    JAMA Netw Open; 2020 Apr; 3(4):e202739. PubMed ID: 32286656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
    Koss CA; Havlir DV; Ayieko J; Kwarisiima D; Kabami J; Chamie G; Atukunda M; Mwinike Y; Mwangwa F; Owaraganise A; Peng J; Olilo W; Snyman K; Awuonda B; Clark TD; Black D; Nugent J; Brown LB; Marquez C; Okochi H; Zhang K; Camlin CS; Jain V; Gandhi M; Cohen CR; Bukusi EA; Charlebois ED; Petersen ML; Kamya MR; Balzer LB
    PLoS Med; 2021 Feb; 18(2):e1003492. PubMed ID: 33561143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi.
    Mukherjee PK; Chandra J; Retuerto M; Sikaroodi M; Brown RE; Jurevic R; Salata RA; Lederman MM; Gillevet PM; Ghannoum MA
    PLoS Pathog; 2014 Mar; 10(3):e1003996. PubMed ID: 24626467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients.
    Hu X; Wang H; Yu B; Yu J; Lu H; Sun J; Sun Y; Zou Y; Luo H; Zeng Z; Liu S; Jiang Y; Wu Z; Ren Z
    Adv Sci (Weinh); 2023 Jul; 10(19):e2205058. PubMed ID: 37119437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mycobiome of root canal infections is correlated to the bacteriome.
    Persoon IF; Buijs MJ; Özok AR; Crielaard W; Krom BP; Zaura E; Brandt BW
    Clin Oral Investig; 2017 Jun; 21(5):1871-1881. PubMed ID: 27771826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an exploratory qualitative assessment among U.S. clients and providers.
    Bardon AR; Simoni JM; Layman LM; Stekler JD; Drain PK
    AIDS Res Ther; 2020 Aug; 17(1):50. PubMed ID: 32762713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.